Wilson Heredia Nunez
Neurology with Special Qualifications in Child Neurology · Miami, FLNPI 1255776589
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $802 and has fallen 61.1% since, to $312 in 2025. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in FL, where the typical reported total is $2,700.
Across 59 payments — averaging $36.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$410
- UCB, Inc.$310
- Lundbeck LLC$253
- Neurelis, Inc.$199
- AbbVie$169
- Biohaven Pharmaceuticals, Inc.$145
- plus $693 from 12 others
Across 10 payments — averaging $9838.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$52K
- Pfizer$47K
What the payments were for
- Food & beverage$2,179100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 14 | $410 |
| UCB, Inc. | 7 | $310 |
| Lundbeck LLC | 2 | $253 |
| Neurelis, Inc. | 5 | $199 |
| AbbVie(2 entities) | 2 | $169 |
| Biohaven Pharmaceuticals, Inc. | 1 | $145 |
| Sumitomo Pharma America, Inc. | 5 | $131 |
| Sanofi | 1 | $108 |
| Ironshore Pharmaceuticals Inc. | 6 | $91 |
| Pfizer | 1 | $76 |
| Corium, LLC | 5 | $74 |
| Livanova USA, Inc. | 2 | $54 |
| Azurity Pharmaceuticals, Inc. | 2 | $48 |
| Catalyst Pharmaceuticals, Inc. | 2 | $34 |
| SK Life Science, Inc. | 1 | $24 |
| Biogen | 1 | $23 |
| Aprecia Pharmaceuticals, LLC | 1 | $16 |
| Tris Pharma Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,179 in reported general payments places this provider in the 45th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Miami
- Trevor ResnickMiami$230K
- Migvis MonduyMiami$188K
- Elza VasconcellosMiami$170K
- Ian MillerMiami$104K
- Matt LallasMiami$88K
- Marytery FajardoMiami$44K
- Paula SchleiferMiami$31K
- Roberto Lopez-AlberolaMiami$31K
- Anuj JayakarMiami$24K
- Walter BradleyMiami$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.